# Contact Reviews PT-141: Corrections and Editorial Inquiries

> Contact the editors of Reviews PT-141, an independent evidence-appraisal project on PT-141 (bremelanotide). For corrections and editorial questions — not medical advice.

Corrections, sourcing questions, and editorial inquiries about our PT-141 (bremelanotide) coverage.

## Editorial inquiries

Reviews PT-141 is an editorial project covering the published research on PT-141 (bremelanotide). We welcome corrections, source suggestions, and questions about how we appraised a particular study. If you believe we have misread a trial, misstated a figure, or missed a relevant paper, tell us which page and which citation and we will review it against the source.

## What we cannot help with

We cannot answer questions about whether or how any individual should use PT-141, and we do not provide medical advice, prescriptions, dosing guidance, or referrals. We do not sell, source, or arrange access to any compound, and we cannot evaluate the contents of any research-chemical product. Questions about personal use belong with a qualified, licensed clinician who can see your full medical context.

## Send a message

Use the form below for corrections and editorial inquiries. Please include the page URL and the citation number you are writing about so we can trace it to the source quickly. We read every message; we cannot promise a reply to questions that ask for individual medical or dosing guidance.

---

A garnet-ruled critical appraisal of the PT-141 (bremelanotide) record — each finding set beside its caveat, the lone approved use (premenopausal HSDD) held apart from the off-label edges and the no-oversight research-chemical form, and every figure weighed rather than quoted; an evidence-reading desk, not a clinic, and nothing here dosed, sourced, or sold.